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TABLE 1. Twenty three most abundant transcripts of IL-5-differentiated UCC
Description of GenBankTM sequence* percentage abundance{
Eosinophil major basic protein mRNA 8?12
Eosinophil Charcot-Leyden crystal protein mRNA 2?98
UDP-GalNAc: polypeptide
N-acetylgalactosaminyltransferase mRNA 1?31
Eosinophil-derived neurotoxin mRNA 1?26
MBP homolog mRNA 1?14
Secretory granule proteoglycan core gene 1?09
Elongation factor EF-1-gene 1?06
Eosinophil peroxidase gene 0?95
Osteopontin mRNA 0?92
Ferritin light subunit mRNA 0?89
Cathepsin B mRNA 0?83
Transcription factor Sp1 mRNA 0?78
CpG island DNA genomic MseI fragment 0?72
Interferon-inducible mRNA 0?66
HLA-DR antigen-chain mRNA 0?54
Cathepsin D mRNA 0?50
Cytoplasmic-actin gene 0?49
3-Hydroxy-3-methylglutaryl coenzyme A synthase mRNA 0?47
NMB mRNA 0?47
-Interferon-inducible protein mRNA 0?40
Glyceraldehyde-3-phosphate dehydrogenase gene 0?40
Ribosomal protein S3a gene 0?40
Ia-associated invariant-chain gene 0?40
*All sequences listed are of human origin.
{Percentage abundance among 8146 total clonses sequenced.
Used with permission from ref.2.
1012 ABSTRACTSantibodies do not distinguish MBP from MBPH. Selection
of specific monoclonal antibodies to MBPH has permitted
establishment of a specific immunoassay for MBPH. In
this assay it is critical that MBPH be reduced and
alkylated in order to detect maximal reactivity. This
behavior of MBPH parallels that of MBP. Immunofluor-
escence examination of MBPH suggests that it is
present in eosinophils and basophils. By immunoelectron
microscopy MBPH has been localized to the eosinophil
granule. Finally, genomic clones for MBPH have been
identified and sequenced and chromosomal localization is
underway.
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Defenses, Bethesda, Maryland, U.S.A.The eosinophil ribonucleases, eosinophil-derived neurotox-
in (EDN) and eosinophil cationic protein (ECP) are among
the major secretory effector proteins of human eosinophilic
leukocytes, cells whose roles in host defense remain poorly
understood. Eosinophils have been implicated in the
pathophysiological process of wheezing in patients with
respiratory viral infections leading us to question the role of
eosinophil-derived ribonucleases in viral infections. Our
recent studies show that eosinophils are recruited to, and
degranulate in, the lung parenchyma of infants infected
with respiratory syncytial virus (RSV), a single stranded
RNA pathogen in the paramyxovirus family (1). These
FIG. 2 Eosinophils (top panel) and neutrophils (bottom
panel) as a percentage of total cells in BAL fluid from
mice before (d 0), and at days 3, 4 and 5 after inoculation
with 300, 60 or 0 pfu PVM.&: 300 pfu; : 60pfu;&0 pfu.
ABSTRACTS 1013infants have high pulmonary concentrations of the eosino-
phil chemoattractants RANTES and MIP-1-a during
ongoing RSV replication, the levels of which correlate
strongly with measured ECP concentrations (Fig. 1). In
vitro data suggests that the source of these chemoattrac-
tants is, at least in part, the pulmonary epithelial cell (2).
Moreover, ribonuclease activity was five-fold higher in
secretions obtained from RSV-infected patients when
compared to controls, and immunoreactive EDN was
present in secretions of all RSV infected infants, but not
in controls. Lung recruitment of eosinophils with release of
their biologically active ribonucleases during RSV infection
may represent a primary immune mechanism designed to
blunt viral replication, as eosinophils and eosinophil
ribonucleases possess anti-RSV activity (3,4). We speculate
that eosinophils possess beneficial roles in RSV disease
through direct inhibition of RSV replication and continue
to investigate the interactions between RSV, pulmonary
epithelium, and eosinophil-derived ribonucleases. To ad-
dress this possibility, a reliable animal model of paramyx-
ovirus infection is necessary. We developed a mouse model
of viral infection caused by pneumonia virus of mice
(PVM), a paramyxovirus related to human RSV. To date,
we have demonstrated that eosinophils are recruited to, and
degranulate in, the lung of PVM infected mice. The
eosinophils are seen in the lung parenchyma as well as in
bronchoalveolar lavage fluid of infected mice. The promi-
nent eosinophilic response seen in BAL fluid peaked on day
3, persisted through day 5, and disappeared by day 7 post-
infection (Fig. 2). Ribonuclease activity in BAL fluid
correlated directly with eosinophil numbers (Fig. 3)
suggesting that eosinophils are activated by and degranu-
late in response to PVM infection. PVM infection is also
accompanied by the production of MIP-1-a but expression
of RANTES, eotaxin and IL-5 levels are no different when
compared to uninfected animals. These observations
indicate that murine eosinophils are elicited and activated
in response to infection with PVM in vivo, providing us withFIG. 1 Line of unity and bivariate scattergram of MIP-1-a
vs. ECP concentration in 48 lower respiratory tract
samples obtained from infants with and without severe
RSV infection (r2=0?868).
FIG. 3 Ribonucelases are among the major secretory
effector proteins of murine eosinophils. The plot
demonstrates the correlation between the number of
eosinophils per ml BAL fluid and units of ribonuclease
activity suggesting that the eosinophils are activated and
degranulating (r2=0?4).a physiological model with which to study the role of
eosinophils and their secretory ribonucleases in host
defense against respiratory viral pathogens. The consistent
observation that MIP-1-a is upregulated in response to
paramyxovirus infection (PVM in mice and RSV in
humans) is particularly interesting given its known ability
to both attract eosinophils and induce eosinophil degranu-
lation. Infecting mice with the human paramyxovirus, RSV
is more challenging as the virus is less pathogenic to rodents
than it is to humans. Using high viral inocula, we have
found that RSV infected mice also increase pulmonary
expression of the eosinophil chemoattractant MIP-1-a.
Studies to determine whether eosinophils are recruited to,
1014 ABSTRACTSand degranulate in, the lungs of RSV infected animals are
underway.
Future experiments designed to elucidate the physiologi-
cal importance of eosinophils in viral respiratory infections
are being performed in transgenic mice that are unable to
mount an eosinophil response to the infection. Because
RSV-induced MIP-1-a concentrations correlate with ribo-
nuclease activity and measurable ECP concentrations in
human infants with RSV bronchiolitis, we have begun to
evaluate RSV and PVM infection in transgenic mice with
targeted deletions in the MIP-1-a gene. Moreover, given the
importance of IL-5 in eosinophilopoiesis, we have designed
experiments to study the progression of PVM (and RSV)
infection in animals deficient in IL-5 production. Disease
progression and severity in these (and possibly other)
transgenic animals will elucidate whether the eosinophilic
response to viral infection is advantageous or detrimental
to the host. Our long-term goal is to translate what we learn
about eosinophil biology in the context of viral disease to
the development of potent immunomodulatory interven-
tions for related human infections.
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Charcot–Leyden crystals (CLCs), first reported more than
150 years ago by Charcot and Robin, are found in a varietyof tissues, body fluids and secretions as a hallmark of
allergic inflammation involving eosinophils and basophils.
CLC protein, the unique autocrystallizing constituent that
forms these distinctive hexagonal bipyramidal crystals,
became synonymous with eosinophil lysophospholipase
(LPLase) when chromatographic purification of this enzy-
matic activity yielded protein preparations that formed
CLC and contained the CLC protein (1). However, our
cloning of the CLC cDNA revealed a polypeptide of
16?5 kD with 142 amino acids that bore no similarities to
any known sequences of LPLases, phospholipases or other
lipolytic enzymes, but that had some similarities to
members of the superfamily of S-type lactose-binding and
IgE-binding animal lectins (2). Our subsequent solution of
the X-ray crystallographic structure of CLC protein
showed that its overall tertiary fold was highly similar to
that of the prototype galectins (Gal) (3), members of the b-
galactoside binding animal lectin superfamily. The struc-
ture of CLC protein provided details of a carbohydrate
recognition domain (CRD) with both similarities to and
differences from other members of the galectin family.
These structural findings, the observation of apparently
weak anity for lactosamine-containing sugars (3,4), and a
conserved genomic structure comparable to other galectins
(5), provided compelling evidence that CLC should be
designated Galectin-10 (6), the 10th member of the
mammalian galectin family. Most recently, using X-ray
crystallographic approaches, we have demonstrated that
CLC protein does not have an anity for b-galactosides,
but instead binds mannose in a unique manner that is
different from the binding of lactosamine sugars by other
related galectins (7). A detailed analysis of the topology and
chemical nature of CLC protein’s CRD in complex with
mannose has provided the first picture of carbohydrate
recognition by this unique lectin. These findings are
providing new clues towards understanding the potential
intracellular and extracellular roles for CLC protein in
eosinophil and basophil biology and in inflammation.
The X-ray crystal structure of CLC protein at 1?8A˚, from
crystals identical in morphology to the crystals found in
vivo, showed that the protein has a ‘jelly-roll’ motif that
results from a tight association between a five-stranded and
a six-stranded b-sheet joined by two 310 helices at the two
ends (3). The overall structural fold of CLC protein is
highly similar to that of galectins-1, -2, and -3, but most
similar to Galectin-7 (8), while sharing only moderate
amino acid sequence identity (*20%) with members of the
galectin superfamily. CLC protein has a CRD containing
nine of the 13 conserved residues in the CRD of galectins-1,
-2, and -7, sharing six of eight residues directly involved in
b-galactoside binding by these galectins (3). This was
apparently borne out by carbohydrate binding studies using
solid-phased simple sugars (3,4); CLC protein was
reported to have specific, but weak, carbohydrate binding
activity for N-acetyl-D-glucosamine and lactose (3,4), but
the mode of carbohydrate binding was not established.
However, our recent studies clearly show that these weak
carbohydrate binding activities can be attributed to
Galectin-10 binding to the crossed-linked agarose (or
Sepharose) matrix and not to the solid-phased lactosa-
